SLC2A3 and hepatocellular carcinoma: We further observed enhanced glycolysis by CLCF1 via PI3K/AKT signaling activation and the glycolytic genes GLUT3, HK2, and PDK1 functioning downstream in sorafenib-resistant HCC cells.